Inspire Medical Systems

General Information


We are a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Our proprietary Inspire system is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. We have developed a novel, closed-loop solution that continuously monitors a patient’s breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway.

Employees: 121
Founded: 2007
Contact Information
Address 9700 63rd Avenue North, Suite 200, Maple Grove, MN 55369, US
Phone Number (844) 672-4357
Web Address
View Prospectus: Inspire Medical Systems
Financial Information
Market Cap $323.8mil
Revenues $28.6 mil (last 12 months)
Net Income $-17.5 mil (last 12 months)
IPO Profile
Symbol INSP
Exchange NYSE
Shares (millions): 6.8
Price range $16.00 - $16.00
Est. $ Volume $108.0 mil
Manager / Joint Managers BofA Merrill Lynch/ Goldman Sachs
CO-Managers Guggenheim Securities/ Stifel/ Wells Fargo Securities
Expected To Trade: 5/3/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change